Innovative medicines initiative (IMI) seminar

This seminar raised awareness of the Innovative Medicines Initiative (IMI) amongst the UK academic sector and provided an opportunity to explore how they might become involved.

The IMI is a public-private partnership between the European Commission, through its 7th Research Framework Programme, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The IMI Joint Technology Initiative will have a budget of 2 billion euros to support biomedical R&D over five years. Investment will be allocated through targeted calls to address current bottlenecks in the biomedical innovation R&D process. Further details can be found at

FB Twitter Instagram Youtube